From lab to life: How Granlab’s formulations are rooted in empathy and real-life stories

We believe that science does not begin with just a simple molecule; it begins with an individual and their needs. With every formulation that we create, we use inspiration from real experiences, challenges and a commitment to delivering safe, effective, steroid-free health solutions rooted in empathy.  

When science meets sensitivity 

We were founded with a clear vision: to develop health solutions that are not only scientifically sound, but deeply human. Driving our mission is our founder, Dr Pragya Sharma, a biochemist whose personal journey has inspired our values from day one.  

Over the past few years, Pragya and our team have developed GL-1, our pioneering topical treatment. Designed to target inflammatory pathways such as IL-17A, SIRT1 and STAT3, GL-1 delivers rapid relief without relying on steroids, setting a new standard for responsible, long-term care.  

How our journey began  

Pragya’s grandmother lived with chronic psoriasis and was experiencing the harmful side effects from prolonged use, such as sight loss and diabetes. Her personal need led Pragya to develop a bioactive, biomineral-based prototype, which cleared her symptoms and inspired the creation of Granlab.  

Inspired by her grandmother’s struggles, Pragya wanted to ensure that individuals with chronic skin conditions no longer had to choose between relief and long-term skin health.  

Our philosophy 

We understand that the long-term use of steroids often leads to rebound symptoms, thinning skin, and withdrawal. That’s why our product development is grounded in a “steroid-free by design” philosophy. We use a unique blend of clinically evaluated natural compounds, molecular targeting, and formulation precision to create treatments that are fast-acting, long-lasting, and gentle on sensitive areas – whilst also being appropriate for usage for every type and colour of skin.  

Our goal is not just alleviating symptoms but restoring trust in what healthcare can look and feel like.  

Backed by Science, Built by Trust 

Our approach has always been evidence-led. In early clinical trials, over 60% of participants remained symptom-free up to four years after using GL-1. Across a cohort of more than 300 patients, 70-80% reported meaningful improvement without the use of steroids- demonstrating the longevity of our approach.  

As we prepare for UK market entry, we remain committed to creating formulations that deliver both measurable results and meaningful relief.  

Empathy is at the core of what we do 

In our lab, every formulation is guided by a central principle; science must serve the real needs of real people. That means listening to people first, designing inclusively, and creating with purpose, from our ingredients to our upcoming community support efforts.  

Our founder, Dr Pragya Sharma, set out to build something different. Today, we continue to push forward with that same intent of blending science with sensitivity and empathy.  

Discover more here.